Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03331939
Other study ID # 938884
Secondary ID
Status Terminated
Phase N/A
First received November 1, 2017
Last updated November 1, 2017
Start date January 6, 2017
Est. completion date October 31, 2017

Study information

Verified date October 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this investigation is data pilot study of the effect of theta frequency stimulation of the vagus nerve on cognitive performance in patients with refractory epilepsy. We will compare the effects of no stimulation, theta frequency (5 Hz), and 'standard' beta frequency stimulation (25-30 Hz) on cognitive measures. We hypothesize that theta frequency VNS will have a positive effect on memory retention. The goal of this study to provide initial data to inform the design of a larger clinical trial to examine the efficacy of theta VNS.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date October 31, 2017
Est. primary completion date October 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Diagnosis of Refractory Epilepsy

2. Previously implanted vagal nerve stimulator

3. Willingness and ability to undergo temporary changes to their VNS device settings

Exclusion Criteria:

1. <18 years of age

2. Adults unable to consent

3. Pregnant women

4. Prisoners

5. >20 on the Beck Depression Inventory (BDI)

6. <24 on the Montreal Cognitive Assessment (MOCA)

7. Adults with diagnosis of developmental delay, intellectual disability, or traumatic brain injury (TBI).

8. Adults with reported history of learning disability.

9. Adults unable to use a computer with their dominant hand.

10. Status Epilepticus within the past 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no stimulation
Vagal nerve stimulator will be set to no stimulation
beta (25-30 Hz)
Vagal nerve stimulator will be set to beta (25-30 Hz)
Theta (5 Hz)
Vagal nerve stimulator will be set to beta (5 Hz)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary California Verbal and Learning Test 2nd edition group 1 Test scored with lower values indicating worse memory and higher values indicating better memory.
Minimum Value:
-16
Maximum Value:
16
hour 1.5
Primary California Verbal and Learning Test 2nd edition group 2 Test scored with lower values indicating worse memory and higher values indicating better memory.
Minimum Value:
-16
Maximum Value:
16
hour 2.25
Primary California Verbal and Learning Test 2nd edition group 3 Test scored with lower values indicating worse memory and higher values indicating better memory.
Minimum Value:
-16
Maximum Value:
16
hour 3
See also
  Status Clinical Trial Phase
Completed NCT02866240 - Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy N/A
Withdrawn NCT04753983 - A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy N/A
Completed NCT01899898 - Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy Phase 2/Phase 3
Recruiting NCT05493722 - Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy Early Phase 1
Recruiting NCT03062514 - Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy N/A
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Recruiting NCT05232630 - Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes Phase 4
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Not yet recruiting NCT04542629 - Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children Phase 4
Terminated NCT03570489 - Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy: N/A
Completed NCT05031208 - Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy N/A
Completed NCT01880333 - Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy Phase 2/Phase 3
Completed NCT03676569 - Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy Phase 1
Withdrawn NCT03115489 - Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus Phase 2/Phase 3
Completed NCT02876289 - Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon) N/A
Completed NCT01521754 - Product Surveillance Registry- Deep Brain Stimulation for Epilepsy
Recruiting NCT04684797 - Localization of the Reward Positivity to ACC N/A
Completed NCT05292183 - Modulation of Emotion Perception in Humans Via Amygdala Stimulation N/A
Terminated NCT04398667 - European Non-interventional Study on Refractory Epilepsy With Developmental Delay
Active, not recruiting NCT04218812 - Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation N/A